Harvard Psychiatrists Under Fire for Drug-Company Funding

A controversial Harvard psychiatrist whose research and recommendations have paved the way for the wide use of antipsychotic drugs in kids has received more than $1.6 million in consulting fees from drugmakers since 2000, and he failed to properly disclose much of the funding, the New York Times reports.
Joseph Biederman (pictured) is a polarizing figure [...]